NCT06585475

Brief Summary

In this study, it was aimed to evaluate the effectiveness of the training structured according to the PMS symptom map. This experimental (randomised-controlled) study was conducted with women of reproductive age with PMS. Women who met the inclusion criteria and volunteered to participate in the study constituted the sample of the study. As a result of block randomisation, 55 women were assigned to the intervention group and 55 women to the control group. Pre-test data were collected from the women allocated to the intervention and control groups by means of data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, Premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale). The intervention group received a 3-session structured training according to the PMS symptom map, while the control group did not receive any intervention. Women in the intervention group completed the post-test data on the last day of the 2nd cycle after the training, while women in the control group completed the post-test data on the last day of the 2nd cycle after the pre-test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 5, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

September 3, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 5, 2024

Completed
Last Updated

September 5, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

September 3, 2024

Last Update Submit

September 3, 2024

Conditions

Keywords

life satisfactionpaindepressionstressanxiety

Outcome Measures

Primary Outcomes (4)

  • Premenstrual syndrome assessment scale

    a scale used to measure the degree of premenstrual syndrome

    pre-intervention, 2 month after intervention

  • premenstrual syndrome specific life satisfaction scale

    Premenstrual syndrome specific life satisfaction scale evaluates life satisfaction of women with PMS

    pre-intervention, 2 month after intervention

  • DAS depression stress anxiety assessment scale

    DAS depression stress anxiety assessment scale, evaluates psychological symptoms

    pre-intervention, 2 month after intervention

  • VAS pain score

    1.421 / 5.000 VAS pain score measures pain score

    pre-intervention, 2 month after intervention

Study Arms (2)

Experimental group

EXPERIMENTAL

The intervention group received a 3-session PMS symptom map-structured training by the responsible and first author (ADK). Before the training, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale). After the training, post-test data were collected on the last day of the 1nd cycle.

Behavioral: Structured training according to premenstrual syndrome symptom map

Control group

NO INTERVENTION

No intervention was applied to the control group. After the participants were divided into groups by randomization, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety rating scale, premenstrual syndrome rating scale and premenstrual syndrome specific life satisfaction scale). After the pre-test, post-test data were collected on the last day of the cycle after 1 menstrual cycles.

Interventions

A symptom map consisting of evidence-based practices for coping with PMS symptoms was created. An educational content based on this map was prepared and applied to women with PMS to evaluate whether it was effective compared to the control group.

Experimental group

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Meeting ACOG's PMS diagnostic criteria Being over 18 years of age, Not using psychotherapeutic medications, Not having a mental illness, Not being pregnant, Agreeing to participate in the study

You may not qualify if:

  • Not having regular menstruation in the last 3 months, Using analgesics during menstruation while participating in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sakarya University

Sakarya, 54050, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premenstrual SyndromeMenstruation DisturbancesPersonal SatisfactionPainDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorNeurologic ManifestationsSigns and SymptomsBehavioral SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2024

First Posted

September 5, 2024

Study Start

November 1, 2023

Primary Completion

June 10, 2024

Study Completion

August 5, 2024

Last Updated

September 5, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations